<p>A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, financial daily Mint <a href="http://www.livemint.com/news/india/govt-panel-to-review-vaccine-side-effects-11617907384480.html" target="_blank">reported</a> on Friday, citing two people aware of the development.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>India is currently administering AstraZeneca's Covid-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called Covaxin.</p>.<p>The review comes after Europe's drug regulator said on Wednesday it found a possible link between AstraZeneca's vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccine's advantages still outweighed the risks.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/are-some-covid-19-vaccines-more-effective-than-others-971882.html" target="_blank">Are some Covid-19 vaccines more effective than others?</a></strong></p>.<p>India is banking on vaccinations to help contain a record surge in cases in its second wave. The country reported a massive 1,26,789 new Covid-19 cases on Thursday.</p>.<p>"We are looking at side-effects of blood clots that have been seen in people who received Covishield and Covaxin, even if it was a mild case," a source told Mint, who added that a report on it was likely to be ready by next week.</p>.<p>Following Europe's announcement, several countries have announced restrictions on the use of the AstraZeneca vaccine in younger people. </p>
<p>A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, financial daily Mint <a href="http://www.livemint.com/news/india/govt-panel-to-review-vaccine-side-effects-11617907384480.html" target="_blank">reported</a> on Friday, citing two people aware of the development.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>India is currently administering AstraZeneca's Covid-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called Covaxin.</p>.<p>The review comes after Europe's drug regulator said on Wednesday it found a possible link between AstraZeneca's vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccine's advantages still outweighed the risks.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/are-some-covid-19-vaccines-more-effective-than-others-971882.html" target="_blank">Are some Covid-19 vaccines more effective than others?</a></strong></p>.<p>India is banking on vaccinations to help contain a record surge in cases in its second wave. The country reported a massive 1,26,789 new Covid-19 cases on Thursday.</p>.<p>"We are looking at side-effects of blood clots that have been seen in people who received Covishield and Covaxin, even if it was a mild case," a source told Mint, who added that a report on it was likely to be ready by next week.</p>.<p>Following Europe's announcement, several countries have announced restrictions on the use of the AstraZeneca vaccine in younger people. </p>